GlaxoSmithKline (Belgium)

Publications in OpenAlex of which a co-author is affiliated to this organization

All publications | By field | By subfield

All publications [Next]
Title DOI
https://doi.org/10.1016/j.ejca.2008.10.026 New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)
https://doi.org/10.1016/s0140-6736(13)60844-2 Burden and aetiology of diarrhoeal disease in infants and young children in developing countries (the Global Enteric Multicenter Study, GEMS): a prospective, case-control study
https://doi.org/10.1002/ijc.22527 Human papillomavirus type distribution in invasive cervical cancer and high‐grade cervical lesions: A meta‐analysis update
https://doi.org/10.1016/s0140-6736(09)61248-4 Efficacy of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): final analysis of a double-blind, randomised study in young women
https://doi.org/10.1016/s0140-6736(04)17398-4 Efficacy of a bivalent L1 virus-like particle vaccine in prevention of infection with human papillomavirus types 16 and 18 in young women: a randomised controlled trial
https://doi.org/10.1056/nejmoa1501184 Efficacy of an Adjuvanted Herpes Zoster Subunit Vaccine in Older Adults
https://doi.org/10.1016/s0140-6736(07)60946-5 Efficacy of a prophylactic adjuvanted bivalent L1 virus-like-particle vaccine against infection with human papillomavirus types 16 and 18 in young women: an interim analysis of a phase III double-blind, randomised controlled trial
https://doi.org/10.2471/blt.07.040089 Vaccination greatly reduces disease, disability, death and inequity worldwide
https://doi.org/10.1128/jvi.79.16.10108-10125.2005 Human Immunodeficiency Virus Type 1envClones from Acute and Early Subtype B Infections for Standardized Assessments of Vaccine-Elicited Neutralizing Antibodies
https://doi.org/10.1056/nejmoa1603800 Efficacy of the Herpes Zoster Subunit Vaccine in Adults 70 Years of Age or Older
https://doi.org/10.1056/nejmoa0904797 Effect of Human Rotavirus Vaccine on Severe Diarrhea in African Infants
https://doi.org/10.1016/j.vaccine.2016.10.042 Vaccine hesitancy and healthcare providers
https://doi.org/10.1056/nejmoa011915 Glycoprotein-D–Adjuvant Vaccine to Prevent Genital Herpes
https://doi.org/10.1016/s0140-6736(04)17223-1 Efficacy of the RTS,S/AS02A vaccine against Plasmodium falciparum infection and disease in young African children: randomised controlled trial
https://doi.org/10.4049/jimmunol.0901474 AS04, an Aluminum Salt- and TLR4 Agonist-Based Adjuvant System, Induces a Transient Localized Innate Immune Response Leading to Enhanced Adaptive Immunity
https://doi.org/10.1002/sim.2302 Tutorial in biostatistics: the self‐controlled case series method
https://doi.org/10.1056/nejmoa2209604 Respiratory Syncytial Virus Prefusion F Protein Vaccine in Older Adults
https://doi.org/10.1016/s1470-2045(11)70286-8 Overall efficacy of HPV-16/18 AS04-adjuvanted vaccine against grade 3 or greater cervical intraepithelial neoplasia: 4-year end-of-study analysis of the randomised, double-blind PATRICIA trial
https://doi.org/10.1016/s0140-6736(06)68304-9 Pneumococcal capsular polysaccharides conjugated to protein D for prevention of acute otitis media caused by both Streptococcus pneumoniae and non-typable Haemophilus influenzae: a randomised double-blind efficacy study
https://doi.org/10.3390/vaccines3020320 Vaccine Adjuvants: from 1920 to 2015 and Beyond
https://doi.org/10.1016/j.smim.2018.05.001 Correlates of adjuvanticity: A review on adjuvants in licensed vaccines
https://doi.org/10.1056/nejmoa1909953 Final Analysis of a Trial of M72/AS01 E Vaccine to Prevent Tuberculosis
https://doi.org/10.1056/nejmoa061847 Safety and Efficacy of a Recombinant Hepatitis E Vaccine
https://doi.org/10.1016/j.jpba.2007.06.013 Harmonization of strategies for the validation of quantitative analytical procedures
https://doi.org/10.1086/600120 Randomized, Double‐Blind, Phase 2a Trial of Falciparum Malaria Vaccines RTS,S/AS01B and RTS,S/AS02A in Malaria‐Naive Adults: Safety, Efficacy, and Immunologic Associates of Protection
https://doi.org/10.1016/s0140-6736(01)06957-4 Efficacy of RTS,S/AS02 malaria vaccine against Plasmodium falciparum infection in semi-immune adult men in The Gambia: a randomised trial
https://doi.org/10.1016/s0140-6736(07)61297-5 Antigen sparing and cross-reactive immunity with an adjuvanted rH5N1 prototype pandemic influenza vaccine: a randomised controlled trial
https://doi.org/10.1016/s1470-2045(11)70287-x Cross-protective efficacy of HPV-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by non-vaccine oncogenic HPV types: 4-year end-of-study analysis of the randomised, double-blind PATRICIA trial
https://doi.org/10.1016/j.vaccine.2006.06.005 Enhanced humoral and memory B cellular immunity using HPV16/18 L1 VLP vaccine formulated with the MPL/aluminium salt combination (AS04) compared to aluminium salt only
https://doi.org/10.1080/14760584.2016.1213632 Adjuvant system AS01: helping to overcome the challenges of modern vaccines
https://doi.org/10.1038/s41541-019-0132-6 The how’s and what’s of vaccine reactogenicity
https://doi.org/10.1016/s1470-2045(16)00099-1 Efficacy of the MAGE-A3 cancer immunotherapeutic as adjuvant therapy in patients with resected MAGE-A3-positive non-small-cell lung cancer (MAGRIT): a randomised, double-blind, placebo-controlled, phase 3 trial
https://doi.org/10.1056/nejmoa1505819 Genetic Diversity and Protective Efficacy of the RTS,S/AS01 Malaria Vaccine
https://doi.org/10.1056/nejmoa1515257 Seven-Year Efficacy of RTS,S/AS01 Malaria Vaccine among Young African Children
https://doi.org/10.1086/523813 Recombinant gp350 Vaccine for Infectious Mononucleosis: A Phase 2, Randomized, Double‐Blind, Placebo‐Controlled Trial to Evaluate the Safety, Immunogenicity, and Efficacy of an Epstein‐Barr Virus Vaccine in Healthy Young Adults
https://doi.org/10.1056/nejmoa0807381 Efficacy of RTS,S/AS01E Vaccine against Malaria in Children 5 to 17 Months of Age
https://doi.org/10.1016/s0140-6736(05)67669-6 Duration of protection with RTS,S/AS02A malaria vaccine in prevention of Plasmodium falciparum disease in Mozambican children: single-blind extended follow-up of a randomised controlled trial
https://doi.org/10.1056/nejmoa1803484 Phase 2b Controlled Trial of M72/AS01 E Vaccine to Prevent Tuberculosis
https://doi.org/10.1016/s0140-6736(08)60524-3 Efficacy and safety of an oral live attenuated human rotavirus vaccine against rotavirus gastroenteritis during the first 2 years of life in Latin American infants: a randomised, double-blind, placebo-controlled phase III study
https://doi.org/10.1016/s0140-6736(09)61208-3 Effect of prophylactic paracetamol administration at time of vaccination on febrile reactions and antibody responses in children: two open-label, randomised controlled trials
https://doi.org/10.1056/nejmoa1008115 A Field Trial to Assess a Blood-Stage Malaria Vaccine
https://doi.org/10.1523/jneurosci.23-30-09796.2003 Nonsteroidal Anti-Inflammatory Drugs and Peroxisome Proliferator-Activated Receptor-γ Agonists Modulate Immunostimulated Processing of Amyloid Precursor Protein through Regulation of β-Secretase
https://doi.org/10.1111/irv.13031 Respiratory syncytial virus disease burden in adults aged 60 years and older in high‐income countries: A systematic literature review and meta‐analysis
https://doi.org/10.1056/nejmoa1411627 A Monovalent Chimpanzee Adenovirus Ebola Vaccine Boosted with MVA
https://doi.org/10.1080/07853890.2017.1407035 Understanding modern-day vaccines: what you need to know
https://doi.org/10.1038/s41591-020-1118-7 A chimeric hemagglutinin-based universal influenza virus vaccine approach induces broad and long-lasting immunity in a randomized, placebo-controlled phase I trial
https://doi.org/10.1038/s41586-021-03530-2 Adjuvanting a subunit COVID-19 vaccine to induce protective immunity
https://doi.org/10.1586/erv.11.192 Development and evaluation of AS03, an Adjuvant System containing α-tocopherol and squalene in an oil-in-water emulsion
https://doi.org/10.1371/journal.pone.0004708 Blood Stage Malaria Vaccine Eliciting High Antigen-Specific Antibody Concentrations Confers No Protection to Young Children in Western Kenya
https://doi.org/10.1097/01.inf.0000197622.98559.01 Burden of Rotavirus Disease in European Union Countries
https://doi.org/10.1056/nejmoa043555 Serum Antibody Responses after Intradermal Vaccination against Influenza
https://doi.org/10.1186/1471-2458-8-381 Determinants of vaccination coverage in rural Nigeria
https://doi.org/10.1016/j.jpba.2007.06.032 Harmonization of strategies for the validation of quantitative analytical procedures
https://doi.org/10.1242/dev.129.22.5151 Requirement of signalling by receptor tyrosine kinase RET for the directed migration of enteric nervous system progenitor cells during mammalian embryogenesis
https://doi.org/10.4049/jimmunol.172.12.7618 Differential Immune Responses and Protective Efficacy Induced by Components of a Tuberculosis Polyprotein Vaccine, Mtb72F, Delivered as Naked DNA or Recombinant Protein
https://doi.org/10.1586/erv.11.29 Recent clinical experience with vaccines using MPL- and QS-21-containing Adjuvant Systems
https://doi.org/10.1073/pnas.1621489114 Systems analysis of protective immune responses to RTS,S malaria vaccination in humans
https://doi.org/10.1016/s1470-2045(15)00047-9 Efficacy of fewer than three doses of an HPV-16/18 AS04-adjuvanted vaccine: combined analysis of data from the Costa Rica Vaccine and PATRICIA trials
https://doi.org/10.1126/science.aab3886 Protective efficacy of adenovirus/protein vaccines against SIV challenges in rhesus monkeys
https://doi.org/10.1093/infdis/jit839 Respiratory Syncytial Virus and Other Respiratory Viral Infections in Older Adults With Moderate to Severe Influenza-like Illness
https://doi.org/10.1016/j.ejca.2008.10.028 Evaluation of lymph nodes with RECIST 1.1
https://doi.org/10.1136/thoraxjnl-2017-210408 Longitudinal profiling of the lung microbiome in the AERIS study demonstrates repeatability of bacterial and eosinophilic COPD exacerbations
https://doi.org/10.1056/nejmoa1410863 Chimpanzee Adenovirus Vector Ebola Vaccine
https://doi.org/10.1073/pnas.2411919121 Global trends in antibiotic consumption during 2016–2023 and future projections through 2030
https://doi.org/10.1056/nejmoa1207564 Four-Year Efficacy of RTS,S/AS01E and Its Interaction with Malaria Exposure
https://doi.org/10.1016/s0140-6736(07)61542-6 Safety of the RTS,S/AS02D candidate malaria vaccine in infants living in a highly endemic area of Mozambique: a double blind randomised controlled phase I/IIb trial
https://doi.org/10.1016/j.cell.2021.05.039 The single-cell epigenomic and transcriptional landscape of immunity to influenza vaccination
https://doi.org/10.1097/inf.0b013e318199f8ef Immunogenicity of the 10-Valent Pneumococcal Non-typeable Haemophilus influenzae Protein D Conjugate Vaccine (PHiD-CV) Compared to the Licensed 7vCRM Vaccine
https://doi.org/10.1016/j.vaccine.2016.10.025 Vaccine impact: Benefits for human health
https://doi.org/10.1086/338834 Prevalence of Enteric Pathogens among International Travelers with Diarrhea Acquired in Kenya (Mombasa), India (Goa), or Jamaica (Montego Bay)
https://doi.org/10.1016/j.vaccine.2010.06.026 Glycoconjugate vaccines and immune interference: A review
https://doi.org/10.1038/nm1009 A CD4+ T-cell immune response to a conserved epitope in the circumsporozoite protein correlates with protection from natural Plasmodium falciparum infection and disease
https://doi.org/10.1038/sj.onc.1208774 Combining lapatinib (GW572016), a small molecule inhibitor of ErbB1 and ErbB2 tyrosine kinases, with therapeutic anti-ErbB2 antibodies enhances apoptosis of ErbB2-overexpressing breast cancer cells
https://doi.org/10.1371/journal.pntd.0004729 The Burden of Cryptosporidium Diarrheal Disease among Children < 24 Months of Age in Moderate/High Mortality Regions of Sub-Saharan Africa and South Asia, Utilizing Data from the Global Enteric Multicenter Study (GEMS)
https://doi.org/10.4161/hv.6.1.9677 From the circumsporozoite protein to the RTS,S/AS candidate vaccine
https://doi.org/10.4049/jimmunol.1400948 Enhancement of Adaptive Immunity by the Human Vaccine Adjuvant AS01 Depends on Activated Dendritic Cells
https://doi.org/10.1097/ppo.0b013e3181eacbd8 Gene Signature in Melanoma Associated With Clinical Activity
https://doi.org/10.1056/nejmoa1614067 Phase 2 Placebo-Controlled Trial of Two Vaccines to Prevent Ebola in Liberia
https://doi.org/10.1001/jama.2019.9053 Effect of Recombinant Zoster Vaccine on Incidence of Herpes Zoster After Autologous Stem Cell Transplantation
https://doi.org/10.1073/pnas.1215165110 Toll-like receptor 4 stimulation with the detoxified ligand monophosphoryl lipid A improves Alzheimer’s disease-related pathology
https://doi.org/10.1016/s1473-3099(19)30163-x Immunogenicity and safety of the adjuvanted recombinant zoster vaccine in adults with haematological malignancies: a phase 3, randomised, clinical trial and post-hoc efficacy analysis
https://doi.org/10.1016/j.vaccine.2004.11.051 Protection of macaques against Mycobacterium tuberculosis infection by a subunit vaccine based on a fusion protein of antigen 85B and ESAT-6
https://doi.org/10.7326/m22-1460 Good Publication Practice (GPP) Guidelines for Company-Sponsored Biomedical Research: 2022 Update
https://doi.org/10.1016/s0140-6736(15)00725-4 Public health impact and cost-effectiveness of the RTS,S/AS01 malaria vaccine: a systematic comparison of predictions from four mathematical models
https://doi.org/10.1016/j.jadohealth.2007.02.015 Immunization of Early Adolescent Females with Human Papillomavirus Type 16 and 18 L1 Virus-Like Particle Vaccine Containing AS04 Adjuvant
https://doi.org/10.1038/s41541-017-0027-3 Cellular and molecular synergy in AS01-adjuvanted vaccines results in an early IFNγ response promoting vaccine immunogenicity
https://doi.org/10.1056/nejmoa0807773 Safety and Immunogenicity of RTS,S/AS02D Malaria Vaccine in Infants
https://doi.org/10.1186/s12879-015-1218-z Modelling estimates of the burden of Respiratory Syncytial virus infection in adults and the elderly in the United Kingdom
https://doi.org/10.1111/j.1398-9995.2006.01054.x Prevalence, classification and perception of allergic and nonallergic rhinitis in Belgium
https://doi.org/10.4049/jimmunol.171.12.6961 Protective Immunity Induced with Malaria Vaccine, RTS,S, Is Linked to Plasmodium falciparum Circumsporozoite Protein-Specific CD4+ and CD8+ T Cells Producing IFN-γ
https://doi.org/10.1056/nejmoa2026330 Seasonal Malaria Vaccination with or without Seasonal Malaria Chemoprevention
https://doi.org/10.1056/nejmoa2031499 Vaccine Efficacy of ALVAC-HIV and Bivalent Subtype C gp120–MF59 in Adults
https://doi.org/10.1093/infdis/jiw237 Fractional Third and Fourth Dose of RTS,S/AS01 Malaria Candidate Vaccine: A Phase 2a Controlled Human Malaria Parasite Infection and Immunogenicity Study
https://doi.org/10.1016/s0140-6736(12)61854-6 Effectiveness of the ten-valent pneumococcal Haemophilus influenzae protein D conjugate vaccine (PHiD-CV10) against invasive pneumococcal disease: a cluster randomised trial
https://doi.org/10.1371/journal.pmed.1001657 Efficacy of Pneumococcal Nontypable Haemophilus influenzae Protein D Conjugate Vaccine (PHiD-CV) in Young Latin American Children: A Double-Blind Randomized Controlled Trial
https://doi.org/10.1002/ijc.27713 Differences in human papillomavirus type distribution in high‐grade cervical intraepithelial neoplasia and invasive cervical cancer in Europe
https://doi.org/10.1097/01.inf.0000141722.10130.50 Efficacy of RIX4414 Live Attenuated Human Rotavirus Vaccine in Finnish Infants
https://doi.org/10.1371/journal.pone.0103293 Carriage of Streptococcus pneumoniae and Other Respiratory Bacterial Pathogens in Low and Lower-Middle Income Countries: A Systematic Review and Meta-Analysis
https://doi.org/10.1097/01.inf.0000178294.13954.a1 Evaluation of Safety, Immunogenicity and Efficacy of an Attenuated Rotavirus Vaccine, RIX4414
https://doi.org/10.1080/21645515.2020.1847582 A systematic literature review of herpes zoster incidence worldwide